Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

A 14-year randomised trial in more than 600 patients has concluded that chemoradiation should remain the standard treatment for patients with locally advanced cervical cancer. The findings are reported today at the ESMO 2017 Congress in Madrid. The trial demonstrated no improved disease-free survival with neoadjuvant chemotherapy followed by surgery.

11 Sep 2017

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.

1 Sep 2017

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

The Southeast's first comprehensive cancer treatment program at the University of Alabama at Birmingham takes patient care to the next level by improving the lives of women affected by or at risk for ovarian cancer.

31 Aug 2017

ASTRO recognizes 43 researchers for their top-rated abstracts at 2017 Annual Meeting

The American Society for Radiation Oncology has selected 43 recipients to be presented with one of its 2017 Annual Meeting Abstract Awards. These individuals will be recognized for their top-rated research abstracts at ASTRO's 59th Annual Meeting, taking place September 24-27 in San Diego.

31 Aug 2017

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

Whenever an organism is damaged, the cells surrounding the wound receive signals to proliferate more intensely so as to regenerate the injured tissue.

26 Aug 2017

Cancer treatments could affect person’s sense of taste and dietary preferences

Cancer treatments have many effects on patients – some apparent and some less so. One of the most noticeable changes is a change in taste.

26 Aug 2017

Tumor irradiation may prolong survival of NSCLC patients undergoing novel chemotherapy formulation

Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years.

26 Aug 2017

Writing your way through cancer

When Lynn Scozzari wrote the beginning lines of that poem, "The Offering," in 2013, she was staring at a photo of a naked woman seated on a rock, her arms thrust open to a valley below. Scozzari herself was in a conference room of the cancer center at Scripps Green Hospital in La Jolla, Calif., seated at a table stocked with coffee and tissues.

26 Aug 2017

Female patients with esophageal cancer have superior response to treatment, study reveals

Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery.

22 Aug 2017

ASTRO commends NRC's final rule that defines medical events for permanent implant brachytherapy

The American Society for Radiation Oncology applauds the United States Nuclear Regulatory Commission for yesterday's announcement of a final rule that updates the definition of medical events for permanent implant brachytherapy and protects patients' access to this treatment.

18 Aug 2017

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

Moffitt Cancer Center and Cvergenx announced a new research partnership that aims to revolutionize radiation therapy. The goal of the Future of Radiation Therapy project is to create a framework for using a patient's genetic information to provide a personalized radiation treatment plan.

9 Aug 2017

Researchers find racial and gender disparities in survival of patients with anal cancer

Over the past 30 years, squamous cell carcinoma of the anus (SCCA) is one of the few cancers with steadily rising incidence in the United States, with the most rapid increase seen in black men.

9 Aug 2017

UCLA research in sarcoma provides much-needed roadmap for personalizing therapies

Sarcoma is a rare and deadly form of cancer occurring in the bones and connective tissue that affects individuals of all ages.

3 Aug 2017

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Aug 2017

ASTRO selects 23 exemplary members to receive Fellows designation

The American Society for Radiation Oncology has selected 23 distinguished members to receive the ASTRO Fellow designation. The 2017 class of Fellows will be recognized during the Awards Ceremony at ASTRO's 59th Annual Meeting, to be held September 24-27 in San Diego.

2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

Antiperspirants can be safely used during breast radiotherapy, study suggests

Women undergoing daily radiation therapy for breast cancer are commonly told they should not use antiperspirant for fear that it could cause greater radiation damage to the skin, but a new study from the Perelman School of Medicine at the University of Pennsylvania shows that advice is not based on sound science.

24 Jul 2017

Advanced lung cancer patients get survival benefit with use of concurrent chemotherapy, proton therapy

For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.

20 Jul 2017

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

Moffitt Cancer Center researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery (neoadjuvant) or after surgery (adjuvant).

17 Jul 2017

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels.

14 Jul 2017

Radiation Therapy News and Research

Further Reading

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

ASTRO recognizes 43 researchers for their top-rated abstracts at 2017 Annual Meeting

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

Cancer treatments could affect person’s sense of taste and dietary preferences

Tumor irradiation may prolong survival of NSCLC patients undergoing novel chemotherapy formulation

Writing your way through cancer

Female patients with esophageal cancer have superior response to treatment, study reveals

ASTRO commends NRC's final rule that defines medical events for permanent implant brachytherapy

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

Researchers find racial and gender disparities in survival of patients with anal cancer

UCLA research in sarcoma provides much-needed roadmap for personalizing therapies

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

ASTRO selects 23 exemplary members to receive Fellows designation

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

Antiperspirants can be safely used during breast radiotherapy, study suggests

Advanced lung cancer patients get survival benefit with use of concurrent chemotherapy, proton therapy

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News